Jean-Yves Pavee is President & VP at ABBOTT LABORATORIES (ABT). They have made 2 open-market trades across 1 company since 2013, most recently 2016-07-01.
CIK 0001580217
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 39,292 | $4.1M |
Shares reported on the most recent Form 4, priced at the 2016-07-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2016-02-29 | 2016-03-02 | $39.24 | $131K | +5.0% | +9.4% | +2.8% |
| ABT | SELL · 10b5-1 | 2016-02-16 | 2016-02-17 | $37.13 | $9K | +1.0% | +6.4% | -1.6% |
| ABT | SELL · 10b5-1 | 2015-06-03 | 2015-06-05 | $49.00 | $515K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-03-02 | 2015-03-03 | $47.48 | $31K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-02-17 | 2015-02-18 | $46.41 | $29K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2014-02-18 | 2014-02-19 | $38.97 | $19K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2013-12-06 | 2013-12-10 | $37.46 | $219K | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.